This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: H. Lundbeck A/s. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Anders Højgaard Hansen: Innovator in Orexin Receptor Agonists
Introduction
Anders Højgaard Hansen is a notable inventor based in Valby, Denmark. He has made significant contributions to the field of pharmacology, particularly in the development of compounds that target the orexin receptor system. His work is essential for advancing treatments related to sleep disorders and other health issues.
Latest Patents
Hansen holds a patent for "Spiromacrocyclic orexin 2 receptor agonists." This invention relates to novel spiro-macrocyclic compounds of general formula (I), which function as Orexin 2 receptor agonists. The patent highlights the potential of these compounds in therapeutic applications.
Career Highlights
Anders Højgaard Hansen is currently employed at H. Lundbeck A/S, a leading pharmaceutical company specializing in brain diseases. His role at Lundbeck allows him to work on innovative solutions that address critical health challenges.
Collaborations
Hansen collaborates with Wanwan Yu, contributing to the advancement of research in their field. Their partnership exemplifies the importance of teamwork in scientific innovation.
Conclusion
Anders Højgaard Hansen's work in developing orexin receptor agonists showcases his commitment to improving health outcomes through innovation. His contributions are vital in the ongoing quest for effective treatments in pharmacology.